Smead Capital Management, Inc. has opened a new $53.0M position in $CROX, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 09-30-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $CROX.
$CROX Hedge Fund Activity
We have seen 246 institutional investors add shares of $CROX stock to their portfolio, and 265 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BOSTON PARTNERS added 1,627,190 shares (+2659.1%) to their portfolio in Q2 2025, for an estimated $164,801,803
- NEW VERNON CAPITAL HOLDINGS II LLC removed 712,520 shares (-99.1%) from their portfolio in Q2 2025, for an estimated $72,164,025
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 639,970 shares (-48.7%) from their portfolio in Q2 2025, for an estimated $64,816,161
- SMEAD CAPITAL MANAGEMENT, INC. added 634,082 shares (+inf%) to their portfolio in Q3 2025, for an estimated $52,977,551
- POINT72 ASSET MANAGEMENT, L.P. added 564,437 shares (+inf%) to their portfolio in Q2 2025, for an estimated $57,166,179
- PUNCH CARD MANAGEMENT L.P. added 531,108 shares (+inf%) to their portfolio in Q2 2025, for an estimated $53,790,618
- MILLENNIUM MANAGEMENT LLC removed 488,539 shares (-80.5%) from their portfolio in Q2 2025, for an estimated $49,479,229
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CROX Insider Trading Activity
$CROX insiders have traded $CROX stock on the open market 4 times in the past 6 months. Of those trades, 3 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CROX stock by insiders over the last 6 months:
- IAN BICKLEY sold 3,044 shares for an estimated $352,784
- JOHN B REPLOGLE has made 2 purchases buying 3,261 shares for an estimated $250,084 and 0 sales.
- SUSAN L. HEALY (EVP, Chief Financial Officer) purchased 2,000 shares for an estimated $153,120
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CROX Analyst Ratings
Wall Street analysts have issued reports on $CROX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 10/21/2025
- Needham issued a "Buy" rating on 08/29/2025
- Keybanc issued a "Overweight" rating on 08/08/2025
- Goldman Sachs issued a "Sell" rating on 07/22/2025
To track analyst ratings and price targets for $CROX, check out Quiver Quantitative's $CROX forecast page.
$CROX Price Targets
Multiple analysts have issued price targets for $CROX recently. We have seen 9 analysts offer price targets for $CROX in the last 6 months, with a median target of $87.0.
Here are some recent targets:
- Peter McGoldrick from Stifel set a target price of $90.0 on 10/31/2025
- Adrienne Yih from Barclays set a target price of $86.0 on 10/31/2025
- Christopher Nardone from B of A Securities set a target price of $98.0 on 10/21/2025
- Anna Andreeva from Piper Sandler set a target price of $75.0 on 09/22/2025
- Tom Nikic from Needham set a target price of $100.0 on 08/29/2025
- Jay Sole from UBS set a target price of $85.0 on 08/11/2025
- Ashley Owens from Keybanc set a target price of $95.0 on 08/08/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $CROX ticker page for more data.
